Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconSGENSeagen$43.15bnn/an/a
us flag iconRVMDRevolution Medicines$32.68bnn/an/a
us flag iconIQVIqvia Holdings$28.04bn19.31n/a
us flag iconINSMInsmed$23.74bnn/an/a
us flag iconBNTXBioNTech SE$22.99bnn/an/a
us flag iconEXASExact Sciences$20.03bnn/an/a
us flag iconASNDAscendis Pharma A/S$15.44bn28.06n/a
us flag iconSMMTSummit Therapeutics$13.56bnn/an/a
us flag iconRGCRegencell Bioscience Holdings$13.35bnn/an/a
us flag iconKRTXKaruna Therapeutics$12.58bnn/an/a
us flag iconIONSIonis Pharmaceuticals$12.52bnn/an/a
us flag iconEXELExelixis$12.48bn16.15n/a
us flag iconMEDPMedpace Holdings$12.28bn27.06n/a
us flag iconMDGLMadrigal Pharmaceuticals$11.84bnn/an/a
us flag iconARWRArrowhead Pharmaceuticals$10.64bnn/an/a
us flag iconCYTKCytokinetics$10.58bnn/an/a
us flag iconPRAXPraxis Precision Medicines$9.77bnn/an/a
us flag iconRXDXPrometheus Biosciences$9.56bnn/an/a
us flag iconICLRIcon$8.90bn11.48n/a
us flag iconIMGNImmunoGen$8.72bnn/an/a